Follow
Vikram R Juneja
Vikram R Juneja
Harvard-MIT Division of Health Sciences and Technology
Verified email at mit.edu
Title
Cited by
Cited by
Year
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
RT Manguso, HW Pope, MD Zimmer, FD Brown, KB Yates, BC Miller, ...
Nature 547 (7664), 413-418, 2017
9672017
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
VR Juneja, KA McGuire, RT Manguso, MW LaFleur, N Collins, ...
Journal of Experimental Medicine 214 (4), 895-904, 2017
7802017
Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth
S Kleffel, C Posch, SR Barthel, H Mueller, C Schlapbach, E Guenova, ...
Cell 162 (6), 1242-1256, 2015
6582015
Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity
AE Ringel, JM Drijvers, GJ Baker, A Catozzi, JC García-Cañaveras, ...
Cell 183 (7), 1848-1866. e26, 2020
3902020
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade
ZA Cooper, VR Juneja, PT Sage, DT Frederick, A Piris, D Mitra, JA Lo, ...
Cancer immunology research 2 (7), 643-654, 2014
2612014
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
AM Paterson, SB Lovitch, PT Sage, VR Juneja, Y Lee, JD Trombley, ...
Journal of Experimental Medicine 212 (10), 1603-1621, 2015
2402015
Suppression by TFR cells leads to durable and selective inhibition of B cell effector function
PT Sage, N Ron-Harel, VR Juneja, DR Sen, S Maleri, W Sungnak, ...
Nature immunology 17 (12), 1436-1446, 2016
2112016
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
CL Tan, JR Kuchroo, PT Sage, D Liang, LM Francisco, J Buck, YR Thaker, ...
Journal of Experimental Medicine 218 (1), 2021
1812021
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly (lactide-co-glycolide) microparticles
C Xu, D Miranda-Nieves, JA Ankrum, ME Matthiesen, JA Phillips, I Roes, ...
Nano letters 12 (8), 4131-4139, 2012
1482012
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes
ZA Cooper, DT Frederick, VR Juneja, RJ Sullivan, DP Lawrence, A Piris, ...
Oncoimmunology 2 (10), e26615, 2013
1172013
Clonal growth of dermal papilla cells in hydrogels reveals intrinsic differences between Sox2-positive and-negative cells in vitro and in vivo
RR Driskell, VR Juneja, JT Connelly, K Kretzschmar, DWM Tan, FM Watt
Journal of Investigative Dermatology 132 (4), 1084-1093, 2012
842012
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells
JM Drijvers, JE Gillis, T Muijlwijk, TH Nguyen, EF Gaudiano, IS Harris, ...
Cancer immunology research 9 (2), 184-199, 2021
832021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
JA Lo, M Kawakubo, VR Juneja, MY Su, TH Erlich, MW LaFleur, ...
Science translational medicine 13 (581), eabd8636, 2021
552021
A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade
IX Chen, K Newcomer, KE Pauken, VR Juneja, K Naxerova, MW Wu, ...
Proceedings of the National Academy of Sciences 117 (38), 23684-23694, 2020
402020
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations
J Choi, SP Goulding, BP Conn, CD McGann, JL Dietze, J Kohler, ...
Cell reports methods 1 (5), 2021
302021
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma
MJ Mooradian, A Reuben, PA Prieto, M Hazar-Rethinam, DT Frederick, ...
Oncoimmunology 7 (5), e1423172, 2018
242018
p73 expression and function in vestibular schwannoma
ZK Ahmad, X Altuna, JP Lopez, Y An, J Wang-Rodriguez, VR Juneja, ...
Archives of Otolaryngology–Head & Neck Surgery 135 (7), 662-669, 2009
92009
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade. Cancer Immunol Res 2014; 2: 643-54; PMID: 24903021
ZA Cooper, VR Juneja, PT Sage, DT Frederick, A Piris, D Mitra, JA Lo, ...
CIR-13-0215, 0
9
Monitoring PD-1 phosphorylation to evaluate PD-1 signaling during antitumor immune responses
X Bu, VR Juneja, CG Reynolds, KM Mahoney, MT Bu, KA McGuire, ...
Cancer immunology research 9 (12), 1465-1475, 2021
82021
Neoantigens and uses thereof
V Juneja
US Patent App. 17/254,128, 2021
42021
The system can't perform the operation now. Try again later.
Articles 1–20